Covariance Association Test (CVAT) Identifies Genetic Markers Associated with Schizophrenia in Functionally Associated Biological Processes

Schizophrenia is a psychiatric disorder with large personal and social costs, and understanding the genetic etiology is important. Such knowledge can be obtained by testing the association between a disease phenotype and individual genetic markers; however, such single-marker methods have limited power to detect genetic markers with small effects. Instead, aggregating genetic markers based on biological information might increase the power to identify sets of genetic markers of etiological significance. Several set test methods have been proposed: Here we propose a new set test derived from genomic best linear unbiased prediction (GBLUP), the covariance association test (CVAT). We compared the performance of CVAT to other commonly used set tests. The comparison was conducted using a simulated study population having the same genetic parameters as for schizophrenia. We found that CVAT was among the top performers. When extending CVAT to utilize a mixture of SNP effects, we found an increase in power to detect the causal sets. Applying the methods to a Danish schizophrenia case–control data set, we found genomic evidence for association of schizophrenia with vitamin A metabolism and immunological responses, which previously have been implicated with schizophrenia based on experimental and observational studies.

[1]  Stefan M. Edwards,et al.  Genomic Prediction for Quantitative Traits Is Improved by Mapping Variants to Gene Ontology Categories in Drosophila melanogaster , 2016, Genetics.

[2]  Gerold Schuler,et al.  Still Alive and Kicking: In-Vitro-Generated GM-CSF Dendritic Cells! , 2016, Immunity.

[3]  P. Sørensen,et al.  Increased prediction accuracy using a genomic feature model including prior information on quantitative trait locus regions in purebred Danish Duroc pigs , 2016, BMC Genetics.

[4]  Pablo Tamayo,et al.  Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation. , 2016, Immunity.

[5]  N. Wray,et al.  Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance components analysis , 2015, Nature Genetics.

[6]  Tadafumi Kato,et al.  Whole genome/exome sequencing in mood and psychotic disorders , 2015, Psychiatry and clinical neurosciences.

[7]  Laura J. Scott,et al.  Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways , 2015, Nature Neuroscience.

[8]  Han Xu,et al.  Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. , 2014, American journal of human genetics.

[9]  J. Nigg,et al.  Functional and genomic context in pathway analysis of GWAS data. , 2014, Trends in genetics : TIG.

[10]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[11]  Doug Speed,et al.  MultiBLUP: improved SNP-based prediction for complex traits , 2014, Genome research.

[12]  Peter M Visscher,et al.  Large-scale genomics unveils the genetic architecture of psychiatric disorders , 2014, Nature Neuroscience.

[13]  Simon C. Potter,et al.  Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.

[14]  Lilian Ricco Medeiros,et al.  Comparative cytogenetic analysis of some species of the Dendropsophus microcephalus group (Anura, Hylidae) in the light of phylogenetic inferences , 2013, BMC Genetics.

[15]  Yen-Tsung Huang,et al.  Gene set analysis using variance component tests , 2013, BMC Bioinformatics.

[16]  Xiaofeng Zhu,et al.  A variance component based multi-marker association test using family and unrelated data , 2013, BMC Genetics.

[17]  R A Ophoff,et al.  Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci , 2013, Molecular Psychiatry.

[18]  Gustavo de los Campos,et al.  Inferences from Genomic Models in Stratified Populations , 2012, Genetics.

[19]  E. Susser,et al.  Low maternal retinol as a risk factor for schizophrenia in adult offspring , 2012, Schizophrenia Research.

[20]  Stephan Ripke,et al.  Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs , 2012, Nature Genetics.

[21]  Jianhua Ruan,et al.  Systematic identification of functional modules and cis-regulatory elements in Arabidopsis thaliana , 2011, BMC Bioinformatics.

[22]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[23]  Erika Cule,et al.  Significance testing in ridge regression for genetic data , 2011, BMC Bioinformatics.

[24]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[25]  Peilin Jia,et al.  Gene set analysis of genome-wide association studies: methodological issues and perspectives. , 2011, Genomics.

[26]  Ofer Levy,et al.  Systemic Stimulation of TLR2 Impairs Neonatal Mouse Brain Development , 2011, PloS one.

[27]  B. Fridley,et al.  Gene set analysis of SNP data: benefits, challenges, and future directions , 2011, European Journal of Human Genetics.

[28]  P. Visscher,et al.  Estimating missing heritability for disease from genome-wide association studies. , 2011, American journal of human genetics.

[29]  Wen Huang,et al.  MTML-msBayes: Approximate Bayesian comparative phylogeographic inference from multiple taxa and multiple loci with rate heterogeneity , 2011, BMC Bioinformatics.

[30]  H. Hakonarson,et al.  Analysing biological pathways in genome-wide association studies , 2010, Nature Reviews Genetics.

[31]  Ayellet V. Segrè,et al.  Hundreds of variants clustered in genomic loci and biological pathways affect human height , 2010, Nature.

[32]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .

[33]  E. Schadt.  Molecular networks as sensors and drivers of common human diseases , 2009, Nature.

[34]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[35]  Manuel A. R. Ferreira,et al.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. , 2009, American journal of human genetics.

[36]  P. VanRaden,et al.  Efficient methods to compute genomic predictions. , 2008, Journal of dairy science.

[37]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[38]  Kai Wang,et al.  Pathway-based approaches for analysis of genomewide association studies. , 2007, American journal of human genetics.

[39]  M. Newton,et al.  Random-set methods identify distinct aspects of the enrichment signal in gene-set analysis , 2007, 0708.4350.

[40]  M. Schwarz,et al.  T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment , 2007, Psychiatry Research.

[41]  Peter Bühlmann,et al.  Analyzing gene expression data in terms of gene sets: methodological issues , 2007, Bioinform..

[42]  Sara van de Geer,et al.  Testing against a high dimensional alternative , 2006 .

[43]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Goodman.  Microarray results suggest altered transport and lowered synthesis of retinoic acid in schizophrenia , 2005, Molecular Psychiatry.

[45]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[46]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[47]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[48]  R. Kahn,et al.  Volume changes in gray matter in patients with schizophrenia. , 2002, The American journal of psychiatry.

[49]  Anil K. Bera,et al.  Rao's score, Neyman's C(α) and Silvey's LM tests: an essay on historical developments and some new results , 2001 .

[50]  A. LaMantia.  Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice , 1999, Biological Psychiatry.

[51]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..

[52]  Kurt Hornik,et al.  On the generation of correlated artificial binary data , 1998 .

[53]  M. Lynch,et al.  Genetics and Analysis of Quantitative Traits , 1996 .

[54]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..